Nanosonics stock has an annual meeting on November 4, 2026
Published on 10/17/2026 at 19:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnnual meeting and valuation
- The annual meeting is scheduled for November 4, 2026.
- The seven-analyst average target fell to AUD 3.88 on September 25, 2026.
- Nanosonics stock was last at AUD 2.86 on October 16, 2026 at 4:10 p.m. AEDT, up 2.33 percent versus the prior ASX close.
- Market capitalization stood at AUD 855.6 million, with a price to earnings ratio of 49.57.
Nanosonics' annual meeting is scheduled for November 4, 2026, according to Simply Wall St. The date gives investors the next formal checkpoint after the company's fiscal 2026 results. The last ASX quotation was AUD 2.86 on October 16, 2026 at 4:10 p.m. AEDT, up 2.33 percent from the prior close of AUD 2.79.
Target remains above the market
On September 25, 2026, Simply Wall St reported that the average target from seven analysts fell from AUD 4.23 to AUD 3.88. At the October 16 price of AUD 2.86, that target stood 35.66 percent above the share price. The target change keeps the analyst view relevant, but the lower figure also marks a more cautious valuation reference than the earlier AUD 4.23 level.
Range leaves room below the high
Nanosonics traded within a 52-week range of AUD 2.64 to AUD 4.76 as of October 16, 2026. The last price was 8.33 percent above the low and 39.92 percent below the high. Trading volume reached 890,157 shares against an average of 1,003,951, leaving the session volume 11.33 percent below its average.
Revenue and margin set the backdrop
The company's fiscal 2026 revenue was AUD 203.90 million, up 2.70 percent from fiscal 2025, while net profit reached AUD 17.80 million, down 14.00 percent. Yahoo Finance reported that constant-currency revenue rose 6.00 percent to AUD 211.50 million and gross margin reached 76.90 percent in fiscal 2026. The same briefing put reported EBIT at AUD 16.00 million and cash at AUD 155.20 million.
Comparison with peers
Nanosonics (ASX, AUD): plus 2.33 percent, price to earnings ratio 49.57, market capitalization AUD 855.6 million.
Cochlear (ASX, AUD): plus 1.87 percent, price to earnings ratio 58.54, market capitalization AUD 8.6 billion.
ResMed (ASX, AUD): plus 2.26 percent, price to earnings ratio 22.98, market capitalization AUD 48.3 billion.
Next date for shareholders
The annual meeting on November 4, 2026 is the next scheduled corporate date. It offers a forum for questions on the AUD 40.00 million buyback, CORIS commercialization and the balance between recurring consumables revenue and new device placements.
Market position
Nanosonics combines a modest fiscal 2026 revenue increase with a lower reported profit and a share price well below its 52-week high. The analyst target remains above the market quotation, while the price to earnings ratio of 49.57 places valuation alongside the operating questions investors will assess at the annual meeting.
The last available ASX quotation stood at AUD 2.86 on October 16, 2026 at 4:10 p.m. AEDT, up 2.33 percent versus the prior ASX close of AUD 2.79.
Nanosonics stock key figures
- Company: Nanosonics Limited
- ISIN: AU000000NAN9
- Ticker: NAN
- Primary exchange: ASX
- Price on ASX (as of October 16, 2026, 4:10 p.m. AEDT): AUD 2.86
- Change on ASX: plus 2.33 percent
- Market capitalization: AUD 855.6 million (as of October 16, 2026)
- 52-week range: AUD 2.64-4.76 (as of October 16, 2026)
- Sector / Industry: Health Technology / infection control and decontamination products
Market context: Market report S&P/ASX 200.
